Anterix (ATEX) Director Jeffrey Altman Receives 1,598-Share Award

What Happened

• Jeffrey A. Altman, a non-employee director and reported 10% owner, was granted 1,598 shares of Anterix common stock on August 4, 2026 as director compensation. The Form 4 reports the acquisition as an award/grant (code A) at $0.00 per share. The shares are restricted and will vest on the earlier of the 2027 annual meeting or August 4, 2027, per the Restricted Stock Agreement.

Key Details

• Transaction date: August 4, 2026; Form 4 filed August 6, 2026 (timely filing).
• Transaction type: Award/Grant (code A); price reported $0.00; total reported value $0.
• Vesting: Shares vest by the earlier of the 2027 Annual Meeting and August 4, 2027 (Footnote F1).
• Ownership after transaction: Not specified in the supplied excerpt (filing does not list aggregate post-transaction holdings here).
• Beneficial ownership notes: Shares are reported for Mr. Altman and may be held for the benefit of Owl Creek Funds; Mr. Altman is managing member of the general partner of the Investment Manager and disclaims beneficial ownership except for any pecuniary interest (Footnotes F2–F5).
• Remark: The Investment Manager may be deemed a director by deputization due to Mr. Altman’s board role.

Context

• This is a routine director compensation award of restricted stock (not a purchase or sale). Such grants are common for non-employee directors and do not necessarily indicate a trading signal. The grant was reported promptly on the Form 4.